The US FDA Grants Orphan Drug Designation to Leads Biolabs’ LBL-034 for Treating Multiple Myeloma #leadsbiolabs #lbl034 #multiplemyeloma #regulatory
PharmaShots
Online Audio and Video Media
Uttar Pradesh, UP 10,965 followers
Incisive news in 3 shots
About us
PharmaShots Media: Your Premier Source for Pharma, Biotech, and MedTech Insights Looking for comprehensive and concise updates from the pharmaceutical, biotech, MedTech, digital health, and life sciences industry? Look no further than PharmaShots. We specialize in delivering summarized news, top trends, and valuable insights, keeping you at the forefront of the latest developments. At PharmaShots, we go beyond just reporting the news. Our team conducts exclusive interviews with key opinion leaders (KOLs), providing you with firsthand perspectives and expert opinions. Additionally, we offer comprehensive coverage of conferences and events, ensuring you never miss out on the industry's important discussions and breakthroughs. In addition to our information-packed content, we provide targeted news alert services, allowing you to receive customized updates tailored to your specific interests and needs. We understand the importance of digital marketing in today's competitive landscape, which is why we offer digital marketing solutions to help your brand reach its target audience effectively. Our online advertising and promotional services further enable you to amplify your presence and engage with industry professionals. Originally established as a media product under Octavus Consulting, PharmaShots has now spun out as an independent entity, PharmaShots Media Private Limited. We are dedicated to serving the life sciences industry by delivering high-quality, timely, and actionable information that empowers professionals like you. For more information about our offerings and how PharmaShots can support your business, please reach out to us at [email protected]. Join us in staying ahead of the curve and making informed decisions in the ever-evolving world of healthcare and life sciences.
- Website
-
https://pharmashots.com
External link for PharmaShots
- Industry
- Online Audio and Video Media
- Company size
- 2-10 employees
- Headquarters
- Uttar Pradesh, UP
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Biotech, MedTech, Digital health, Pharmaceuticals, News, Analysis, Summary, Biosimilars, Conference, Reports, Medical Devices, M&A, Cell & Gene Therapy, Generics, Life Sciences, HealthIT, Newswire, Digital Marketing, Content Writing, and KOL Interview
Locations
-
Primary
Get directions
Noida
Uttar Pradesh, UP 201301, IN
-
Get directions
New Delhi, Delhi 110075, IN
Employees at PharmaShots
Updates
-
The EC Grants Approval to Sanofi and Regeneron’s Dupixent (Dupilumab) for Young Children with Eosinophilic Esophagitis (EoE) #sanofi #regeneron #dupixent #eosinophilicesophagitis #regulatory
Sanofi and Regeneron Reports the EC’s Approval of Dupixent (Dupilumab) for Young Children with Eosinophilic Esophagitis (EoE)
pharmashots.com
-
Boston Scientific Strengthens its Electrophysiology Portfolio Through the Acquisition of Cortex #bostonscientific #cortex #optimapsystem #atrialfibrillation
Boston Scientific Reports the Acquisition of Cortex
pharmashots.com
-
Greetings Readers! PharmaShots presents Insights Key Biosimilars Events of October 2024 The report outlines updates from major Biosimilars in October. With PharmaShots, you get top-grade healthcare reports tailored to your needs. Our diverse range of services is designed to keep up with the growing needs of the healthcare industry. Why wait? Reach out to us at [email protected] Teva Pharmaceuticals Alvotech mAbxience Bio-Thera Solutions Dong-A Pharmaceutical Co.,Ltd Gedeon Richter Pharma GmbH Meitheal Pharmaceuticals, Inc. #biosimilars #biologics #fdaapproval #dongast #imuldosa #plaquepsoriasis #crohnsdisease #psoriaticarthritis #ulcerativecolitis #pharmashots #biosimilarmarketevents
Key Biosimilars Events of October 2024
PharmaShots on LinkedIn
-
Greetings Readers! PharmaShots presents Insights Key Biosimilars Events of October 2024 The report outlines updates from major Biosimilars in October. With PharmaShots, you get top-grade healthcare reports tailored to your needs. Our diverse range of services is designed to keep up with the growing needs of the healthcare industry. Why wait? Teva Pharmaceuticals mAbxience Bio-Thera Solutions Gedeon Richter Pharma GmbH Alvotech Meitheal Pharmaceuticals, Inc. Reach out to us at [email protected]
Key Biosimilars Events of October 2024
pharmashots.com
-
Zymeworks Inc. Doses the First Patient with ZW191 in P-I Study for Treating Folate Receptor-⍺ Expressing Advanced Solid Tumors #zymeworks #zw191 #solidtumors #clinicaltrial #firstpatientdosing
Zymeworks Reports the First Patient Dosing with ZW191 in P-I Study for Treating Folate Receptor-⍺ Expressing Advanced Solid Tumors
pharmashots.com
-
Ascendis Pharma Partners with Novo Nordisk to Develop and Commercialize TransCon Tech-based Products in Metabolic and Cardiovascular Indications #ascendispharma #novonordisk #metaboliccardiovascularindications #pharma
Ascendis Pharma Join Forces with Novo Nordisk to Develop and Commercialize TransCon Tech-based Products in Metabolic and Cardiovascular Indications
pharmashots.com
-
Surrozen Join Forces with TCGFB for Developing TGF-β Antibodies for Idiopathic Pulmonary Fibrosis #surrozen #tcgfb #pharma #tgfβantibodies #idiopathicpulmonaryfibrosis
Surrozen Collaborates with TCGFB for Developing TGF-β Antibodies for Idiopathic Pulmonary Fibrosis
pharmashots.com
-
Xencor Doses the First Healthy Individual with XmAb942 in P-I/II Trial to Treat Inflammatory Bowel Disease #xencor #xmab942 #inflammatoryboweldisease #clinicaltrial
Xencor Reports the First Individual Dosing with XmAb942 in P-I/II Trial to Treat Inflammatory Bowel Disease
pharmashots.com
-
The US FDA Accepts Ionis Pharmaceuticals, Inc.’ NDA of Donidalorsen as a Prophylactic Treatment of Hereditary Angioedema (HAE) #ionispharmaceuticals #donidalorsen #hereditaryangioedema #regulatory
Ionis Reports the US FDA’s NDA Acceptance of Donidalorsen as a Prophylactic Treatment of Hereditary Angioedema (HAE)
pharmashots.com